The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Limited, purchased 4,682 equity shares (0.10%) through open market transactions on June 8, 2026. His holding rose from 9.75% (4,95,975 shares) to 9.85% (5,00,657 shares) of the company's paid-up equity capital. The total equity share capital of the company stands at 50,71,700 shares. The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
A small promoter buy that shows continued confidence in the company, but the increase is marginal and unlikely to move the stock meaningfully. His stake is now just 0.15 percentage points shy of the 10% takeover threshold, which means any further purchases could trigger additional disclosure requirements.